CMS

Clinical trials for CMS explained in plain language.

Never miss a new study

Get alerted when new CMS trials appear

Sign up with your email to follow new studies for CMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for rare muscle disease: experimental drug ARGX-119 enters human testing

Disease control Recruiting now

This early-stage study tests a new medicine called ARGX-119 in 16 adults with a rare genetic condition (DOK7-CMS) that causes muscle weakness. The main goal is to check if the drug is safe and how the body handles it. Participants will receive either the drug or a placebo, and la…

Matched conditions: CMS

Phase: PHASE1 • Sponsor: argenx • Aim: Disease control

Last updated May 17, 2026 12:59 UTC

CMS

Get alerted when new CMS trials appear

New hope for rare muscle disease: experimental drug ARGX-119 enters human testing